← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 6, 2016Last known activity
Apr 3, 2025
Timeline
2010s
- Jan 1, 2013
TenNor Therapeutics Ltd— Founded
Drugs by trial phase (10 distinct, 16 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT06889701Lead sponsorPhase 1/Phase 2Apr 3, 2025
- NCT06551623Lead sponsorPhase 1Aug 26, 2024
- NCT05857163Lead sponsorPhase 3May 18, 2023
- NCT06137573Lead sponsorPhase 1Jul 12, 2022
- NCT06394518Lead sponsorPhase 1Jul 7, 2022
- NCT06076694Study directorPhase 2Jun 26, 2022
- NCT06076694Lead sponsorPhase 2Jun 26, 2022
- NCT05074134Lead sponsorPhase 1Oct 11, 2021
- NCT06076681Lead sponsorPhase 1/Phase 2Sep 27, 2021
- NCT06076681Study directorPhase 1/Phase 2Sep 27, 2021
- NCT06081712Lead sponsorPhase 1Oct 20, 2020
- NCT06081712Study directorPhase 1Oct 20, 2020
- NCT06135675Lead sponsorPhase 1/Phase 2Aug 27, 2020
- NCT04294862Lead sponsorPhase 1Mar 31, 2020
- NCT06081699Study directorPhase 1May 9, 2019
Details
- Founded
- Westfield, NJ, US Jan 1, 2013
- Last known activity
- Apr 3, 2025